Abstract

Depletion of intracellular potassium ions (K +) is necessary for cells to shrink, activate caspases and induce DNA fragmentation, events which are features of apoptosis. Here we describe a 96-well plate method using the cell permeable form of K + binding benzofuran isophtalate (PBFI-AM) to measure intracellular K + content in relation to untreated control. Cultured human pulmonary mesothelioma cells (P31) and small-cell lung cancer cells (U1690) were treated with K + flux modulators in order to deprive the cells of intracellular K +. The combination of K + influx inhibition with 10 μmol/L bumetanide plus 10 μmol/L ouabain and K + efflux stimulation with 3 mg/L amphotericin B or 5 μmol/L nigericin efficiently reduced the intracellular K + content after 3 h. Manipulation of K + fluxes with subsequent intracellular K + depletion induced apoptosis of lung cancer cells, as detected by caspase-3 activity after 3 h K + depletion followed by 24 h proliferation and TUNEL positive staining after 48 h proliferation. We concluded that the PBFI-AM assay was a useful tool to determine intracellular K + content in relation to untreated control, and that intracellular K + depletion of lung cancer cells by clinically used drugs of relevant concentrations induced apoptosis. These findings may lead to novel therapeutic strategies in the treatment of lung cancer.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.